In this presentation, ‘Effective Late Stage Pathways for Biosimilar Products’, Dr. JingPing Yeo, outlines strategies to enhance operational efficiencies, optimize patient recruitment and retention and leverage data driven monitoring for data surveillance in Biosimilar studies.
Learn about ‘Effective Late Stage Pathways for Biosimilar Products’, in this presentation by PAREXEL’s Dr. JingPing Yeo. Dr. Yeo outlines strategies to enhance operational efficiencies, optimize patient recruitment and retention and leverage data driven monitoring for data surveillance in Biosimilar studies.
